US Patent No. 9,410,965

Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
Aug 12, 2016

Battelle Energy Alliance has been awarded US Patent No. 9,410,965, "Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual."

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.